ATE408685T1 - Antimikrobielle peptide, abstammend von ubiquicidin - Google Patents

Antimikrobielle peptide, abstammend von ubiquicidin

Info

Publication number
ATE408685T1
ATE408685T1 AT98925978T AT98925978T ATE408685T1 AT E408685 T1 ATE408685 T1 AT E408685T1 AT 98925978 T AT98925978 T AT 98925978T AT 98925978 T AT98925978 T AT 98925978T AT E408685 T1 ATE408685 T1 AT E408685T1
Authority
AT
Austria
Prior art keywords
ubiquicidine
instance
peptides derived
antimicrobial peptides
peptide
Prior art date
Application number
AT98925978T
Other languages
English (en)
Inventor
Petrus Nibbering
Pieter Hiemstra
Maria Theodora Van D Barselaar
Ernest Pauwels
Rolf Feitsma
Original Assignee
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leiden filed Critical Univ Leiden
Application granted granted Critical
Publication of ATE408685T1 publication Critical patent/ATE408685T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98925978T 1997-05-29 1998-05-29 Antimikrobielle peptide, abstammend von ubiquicidin ATE408685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1006164A NL1006164C2 (nl) 1997-05-29 1997-05-29 Antimicrobiële peptiden.

Publications (1)

Publication Number Publication Date
ATE408685T1 true ATE408685T1 (de) 2008-10-15

Family

ID=19765050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925978T ATE408685T1 (de) 1997-05-29 1998-05-29 Antimikrobielle peptide, abstammend von ubiquicidin

Country Status (8)

Country Link
US (1) US6884776B1 (de)
EP (1) EP1003854B1 (de)
AT (1) ATE408685T1 (de)
AU (1) AU7791398A (de)
CA (1) CA2291894A1 (de)
DE (1) DE69840024D1 (de)
NL (1) NL1006164C2 (de)
WO (1) WO1998054314A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2423525C2 (ru) * 2001-02-23 2011-07-10 ДСМ Ай Пи ЭССЕТС Б.В. Новые гены, кодирующие новые протеолитические ферменты
US7603239B2 (en) * 2004-05-05 2009-10-13 Massachusetts Institute Of Technology Methods and systems for generating peptides
US8252737B2 (en) 2004-12-15 2012-08-28 The Regents Of The University Of Colorado Antimicrobial peptides and methods of use
WO2010042534A1 (en) * 2008-10-06 2010-04-15 The Regents Of The University Of Colorado, A Body Corporate Peptides and methods of use
EP2204377A1 (de) * 2008-12-30 2010-07-07 Commissariat à l'énergie atomique et aux énergies alternatives Cysteinfreie, Technetium- oder Rhenium-chelatisierende Peptidsequenzen und deren Verwendung
EP2437770A4 (de) * 2009-06-05 2013-11-06 Univ Colorado Regents Antimikrobielle peptide
EP3384938A1 (de) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Manipulierte nukleinsäuren und verfahren zur verwendung davon
WO2013151664A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
CN104411338A (zh) 2012-04-02 2015-03-11 现代治疗公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
GB201420221D0 (en) * 2014-11-13 2014-12-31 Univ Edinburgh Molecular probes and methods using the same
GB201420222D0 (en) * 2014-11-13 2014-12-31 Univ Edinburgh Molecular probes and methods using the same
US11168131B2 (en) 2015-11-10 2021-11-09 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
WO2018136626A1 (en) 2017-01-18 2018-07-26 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
KR20240085798A (ko) 2020-04-03 2024-06-17 비스테라, 인크. 항체 분자-약물 접합체 및 이의 용도
KR102569795B1 (ko) * 2021-05-03 2023-08-23 경상국립대학교산학협력단 강도다리에서 유래한 유비퀴틴 관련 신규 항균 펩티드 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3005943B2 (ja) * 1990-04-17 2000-02-07 マリンクロッド・インコーポレイテッド テクネチウム―９９ｍ錯化合物製造のための方法及びキット
JP3009498B2 (ja) * 1991-03-28 2000-02-14 日清製粉株式会社 脂質分解酵素阻害剤
JPH08176193A (ja) * 1994-12-23 1996-07-09 Soosei:Kk 長期増強誘導性ペプチド
US6319503B1 (en) * 1998-02-19 2001-11-20 Proteinix Company Heat shock fusion-based vaccine system

Also Published As

Publication number Publication date
CA2291894A1 (en) 1998-12-03
NL1006164C2 (nl) 1998-12-01
EP1003854B1 (de) 2008-09-17
AU7791398A (en) 1998-12-30
DE69840024D1 (de) 2008-10-30
US6884776B1 (en) 2005-04-26
EP1003854A1 (de) 2000-05-31
WO1998054314A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
BR0010720A (pt) Peptìdeos de neisseria antigênicos
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
ATE368053T1 (de) Antimikrobielle peptide
WO1995021919A3 (en) Protein having tpo activity
CY1108049T1 (el) Πεπτιδια με βαση την αλληλουχια της ανθρωπινης λακτοφερρινης και χρηση τους
SE9100799L (sv) Rekombinant derivat av human faktor viii
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
DE60313982D1 (de) Dimere von thrombinpeptidderivaten
DE69940927D1 (de) PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
DE68905097D1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
AU2003264696A1 (en) Cationic linear peptides having antibacterial and/or antifungal properties
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
DE69623803D1 (de) Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
WO2005005469A3 (en) Novel purified polypeptides from staphylococcus aureus
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
WO2002100897A3 (fr) Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003854

Country of ref document: EP

REN Ceased due to non-payment of the annual fee